Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))

S. Peleg Hasson, M. R. Brezis, E. Shachar, S. S. Shachar, I. Wolf, A. Sonnenblick*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The publisher regrets that at the time the article was published parts of Figure 2A and Figure 3 were missing. This has now been corrected and the correct figures appear below. [Figure presented] [Figure presented] The publisher would like to apologise for any inconvenience caused.

Original languageEnglish
Article number100158
JournalESMO Open
Volume6
Issue number3
DOIs
StatePublished - Jun 2021

Fingerprint

Dive into the research topics of 'Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088] (ESMO Open (2021) 6(2), (S2059702921000454), (10.1016/j.esmoop.2021.100088))'. Together they form a unique fingerprint.

Cite this